
Joshua E. Raizman
Featured in:
onlinecjc.ca
Articles
-
Mar 1, 2024 |
onlinecjc.ca | Dennis J. Orton |Alberta Precision Laboratories |Joshua E. Raizman
Elevated lipoprotein (a) [Lp(a)] levels have been linked to atherosclerotic cardiovascular disease (ASCVD) and various cardiovascular related outcomes. In March 2021, updated Canadian Cardiovascular Society (CCS) dyslipidemia guidelines included a strong recommendation to measure Lp(a) once in a patient’s lifetime as a part of initial lipid screening.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →